Monopar Therapeutics EPS MNPR

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Monopar Therapeutics' earnings per share was −$3.85 over the twelve months to Mar 31, 2022.

In its latest quarter, Q1 FY22, it was −$0.95.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q1 FY22	Mar 31, 2022	−$0.95	n/a	−$3.85
Q4 FY21	Dec 31, 2021	−$1.05	n/a	−$3.70
Q3 FY21	Sep 30, 2021	−$1.00	n/a	−$3.60
Q2 FY21	Jun 30, 2021	−$0.85	n/a	−$3.35
Q1 FY21	Mar 31, 2021	−$0.80	n/a	−$3.20
Q4 FY20	Dec 31, 2020	−$0.95	n/a	−$2.90
Q3 FY20	Sep 30, 2020	−$0.75	n/a	−$2.60
Q2 FY20	Jun 30, 2020	−$0.70	n/a	−$2.25
Q1 FY20	Mar 31, 2020	−$0.50	n/a	−$2.05
Q4 FY19	Dec 31, 2019	−$0.65	n/a	−$2.30
Q3 FY19	Sep 30, 2019	−$0.40	n/a	−$2.15
Q2 FY19	Jun 30, 2019	−$0.50	n/a	−$2.10

Companies in Drug Manufacturers - General nearest Monopar Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
MNPRMonopar Therapeutics	n/m
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
COLLCollegium Pharmaceutical	$1.24	+19% a year
ABUSArbutus Biopharma	$0.78
NATRNatures Sunshine Products	$1.01	+36% a year
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
Peer median	$0.97